In sum, today's market action reflected deepening caution across asset classes, with macro and policy uncertainties intersecting management commentary for a more sober market tone. Investors are closely watching congressional negotiations on Election Day to end the government shutdown and anticipate further…
Pfizer’s (PFE) move to acquire Metsera (Monday, Sept. 22, 2025) for up to $4.9 billion marks a pivotal expansion in the fast-evolving obesity and diabetes treatment market, intensifying the industry’s GLP-1 rivalry among major pharmaceutical players. Modular Medical (NASDAQ: MODD), with its…
Bavarian Nordic, a leading Danish vaccine manufacturer best known for its MVA-BN (Modified Vaccinia Ankara–Bavarian Nordic) smallpox and mpox vaccines, recently agreed to a $2.99 billion takeover by private equity firms Permira and Nordic Capital. Shareholders are being offered 233 Danish kroner…
In the bustling digital amphitheater of Tribe Public’s latest CEO Presentation, the question of the hour was as sharp as it was timely: “Is the beaten down biotech sector the smartest bet in today’s volatile market?” With a flourish of slides and…
